• Home
  • Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer.

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer.

Author List
Schmid P, Adams S, Rugo HS, Schneeweiss A, Barrios CH, Iwata H, Diéras V, Hegg R, Im SA, Shaw Wright G, Henschel V, Molinero L, Chui SY, Funke R, Husain A, Winer EP, Loi S, Emens LA, IMpassion130 Trial Investigators
Publication
The New England journal of medicine
Publication ID (Profile URL)
https://researcherprofiles.org/profile/30197968
Publication Year
2018
PubMed ID
30345906
Publication Title
Schmid P, Adams S, Rugo HS, Schneeweiss A, Barrios CH, Iwata H, Diéras V, Hegg R, Im SA, Shaw Wright G, Henschel V, Molinero L, Chui SY, Funke R, Husain A, Winer EP, Loi S, Emens LA, IMpassion130 Trial Investigators. Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer. N Engl J Med. 2018 11 29; 379(22):2108-2121.